• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新合成的含氟肉桂基哌嗪类化合物具有低体外 MAO-B 结合。

Newly Synthesized Fluorinated Cinnamylpiperazines Possessing Low In Vitro MAO-B Binding.

机构信息

ICTM-Department of Chemistry, University of Belgrade, Njegoševa 12, 11000 Belgrade, Serbia.

Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Permoserstraße 15, 04318 Leipzig, Germany.

出版信息

Molecules. 2020 Oct 26;25(21):4941. doi: 10.3390/molecules25214941.

DOI:10.3390/molecules25214941
PMID:33114548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7663645/
Abstract

Herein, we report on the synthesis and pharmacological evaluation of ten novel fluorinated cinnamylpiperazines as potential monoamine oxidase B (MAO-B) ligands. The designed derivatives consist of either cinnamyl or 2-fluorocinnamyl moieties connected to 2-fluoropyridylpiperazines. The three-step synthesis starting from commercially available piperazine afforded the final products in overall yields between 9% and 29%. An in vitro competitive binding assay using l-[H]Deprenyl as radioligand was developed and the MAO-B binding affinities of the synthesized derivatives were assessed. Docking studies revealed that the compounds - were stabilized in both MAO-B entrance and substrate cavities, thus resembling the binding pose of l-Deprenyl. Although our results revealed that the novel fluorinated cinnamylpiperazines - do not possess sufficient MAO-B binding affinity to be eligible as positron emission tomography (PET) agents, the herein developed binding assay and the insights gained within our docking studies will certainly pave the way for further development of MAO-B ligands.

摘要

在此,我们报告了十种新型氟代肉桂基哌嗪的合成和药理学评价,这些化合物作为潜在的单胺氧化酶 B(MAO-B)配体。设计的衍生物由肉桂基或 2-氟肉桂基部分连接到 2-氟吡啶基哌嗪上。从商业可得的哌嗪开始的三步合成以 9%至 29%的总产率得到最终产物。开发了一种使用 l-[H]Deprenyl 作为放射性配体的体外竞争性结合测定法,并评估了合成衍生物的 MAO-B 结合亲和力。对接研究表明,化合物 - 在 MAO-B 入口和底物腔中均稳定,因此类似于 l-Deprenyl 的结合构象。尽管我们的结果表明,新型氟代肉桂基哌嗪 - 不具有足够的 MAO-B 结合亲和力作为正电子发射断层扫描(PET)剂,但在此开发的结合测定法和我们的对接研究中获得的见解肯定将为 MAO-B 配体的进一步开发铺平道路。

相似文献

1
Newly Synthesized Fluorinated Cinnamylpiperazines Possessing Low In Vitro MAO-B Binding.新合成的含氟肉桂基哌嗪类化合物具有低体外 MAO-B 结合。
Molecules. 2020 Oct 26;25(21):4941. doi: 10.3390/molecules25214941.
2
In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain.氟代茚酮衍生物作为潜在的正电子发射断层扫描剂用于脑中单胺氧化酶 B 成像的体外和体内评价。
Bioorg Med Chem Lett. 2021 Sep 15;48:128254. doi: 10.1016/j.bmcl.2021.128254. Epub 2021 Jul 10.
3
Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.含(2-氟苯基)哌嗪结构部分的哒嗪酮类化合物的设计、合成与生物评价作为选择性 MAO-B 抑制剂。
Molecules. 2020 Nov 17;25(22):5371. doi: 10.3390/molecules25225371.
4
Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).[¹⁸F]氟拉沙吉林的合成与评价,一种新型的单胺氧化酶 B(MAO-B)正电子发射断层扫描(PET)放射性配体。
Bioorg Med Chem. 2012 May 1;20(9):3065-71. doi: 10.1016/j.bmc.2012.02.056. Epub 2012 Mar 3.
5
Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).开发一种新型氟-18 标记氘代氟拉沙敏 ([(18)F]氟拉沙敏-D2) 放射性配体,用于单胺氧化酶 B (MAO-B) 的 PET 研究。
Bioorg Med Chem. 2013 Nov 1;21(21):6634-41. doi: 10.1016/j.bmc.2013.08.019. Epub 2013 Aug 15.
6
Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.新型噻唑基腙-哌嗪衍生物的设计、合成、体外及计算机模拟研究作为选择性 MAO-A 抑制剂。
Molecules. 2020 Sep 22;25(18):4342. doi: 10.3390/molecules25184342.
7
Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.强效且高选择性的双靶 monoamine oxidase-B 抑制剂:吗啉取代的氟查耳酮与咪唑。
Arch Pharm (Weinheim). 2019 Apr;352(4):e1800309. doi: 10.1002/ardp.201800309. Epub 2019 Jan 21.
8
Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from (Damiana).(黄鹌菜)中分离得到的乙酰刺槐素 7-甲醚对人单胺氧化酶 B 的选择性抑制作用。
Molecules. 2019 Feb 23;24(4):810. doi: 10.3390/molecules24040810.
9
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.tau PET 示踪剂与单胺氧化酶 B 的交叉相互作用:来自计算机建模和体内成像的证据。
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1369-1382. doi: 10.1007/s00259-019-04305-8. Epub 2019 Mar 27.
10
Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.一些 6-硝基苯并噻唑衍生的缩氨基脲的设计、合成、体外 MAO-B 抑制评估和计算研究。
ChemMedChem. 2013 Mar;8(3):462-74. doi: 10.1002/cmdc.201200484. Epub 2013 Jan 16.

引用本文的文献

1
Identification of New -methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors.新型N-甲基哌嗪查耳酮作为单胺氧化酶B/乙酰胆碱酯酶双重抑制剂的鉴定
Pharmaceuticals (Basel). 2023 Jan 6;16(1):83. doi: 10.3390/ph16010083.
2
First-in-Humans Evaluation of F-SMBT-1, a Novel F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis.首例人体 F-SMBT-1 评估:一种新型 F 标记单胺氧化酶-B PET 示踪剂,用于成像反应性星形胶质细胞增生。
J Nucl Med. 2022 Oct;63(10):1551-1559. doi: 10.2967/jnumed.121.263254. Epub 2022 Jan 27.

本文引用的文献

1
Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease.吡哆醇-白藜芦醇杂合体作为新型 MAO-B 抑制剂,具有抗氧化和神经保护活性,可用于治疗帕金森病。
Bioorg Chem. 2020 Apr;97:103707. doi: 10.1016/j.bioorg.2020.103707. Epub 2020 Feb 27.
2
Synthesis and preclinical evaluation of [F]FSL25.1188, a reversible PET radioligand for monoamine oxidase-B.用于单胺氧化酶-B的可逆正电子发射断层扫描(PET)放射性配体[F]FSL25.1188的合成及临床前评估
Bioorg Med Chem Lett. 2019 Jul 1;29(13):1624-1627. doi: 10.1016/j.bmcl.2019.04.040. Epub 2019 Apr 27.
3
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
tau PET 示踪剂与单胺氧化酶 B 的交叉相互作用:来自计算机建模和体内成像的证据。
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1369-1382. doi: 10.1007/s00259-019-04305-8. Epub 2019 Mar 27.
4
Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.单胺氧化酶-B 抑制剂作为潜在的神经治疗药物:概述与更新。
Med Res Rev. 2019 Sep;39(5):1603-1706. doi: 10.1002/med.21561. Epub 2019 Jan 2.
5
Nuclear medicine of the cerebellum.小脑的核医学
Handb Clin Neurol. 2018;154:251-266. doi: 10.1016/B978-0-444-63956-1.00015-1.
6
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?不考虑现有结构数据,仅将分子对接得分最高的构象作为最佳解决方案是否可靠?
Molecules. 2018 Apr 28;23(5):1038. doi: 10.3390/molecules23051038.
7
N-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling.N-丙烯酰赖氨酰哌嗪作为转谷氨酰胺酶 2 的不可逆抑制剂:合成、构效关系和药代动力学特征。
J Med Chem. 2018 May 24;61(10):4528-4560. doi: 10.1021/acs.jmedchem.8b00286. Epub 2018 May 10.
8
Strategies to facilitate the discovery of novel CNS PET ligands.促进新型中枢神经系统正电子发射断层扫描(PET)配体发现的策略。
EJNMMI Radiopharm Chem. 2017;1(1):13. doi: 10.1186/s41181-016-0016-2. Epub 2016 Sep 13.
9
Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.苯并哌嗪/苯并哌嗪衍生物的合成、生物评价及分子模拟研究作为潜在的 MAO 抑制剂。
Bioorg Chem. 2018 Apr;77:252-262. doi: 10.1016/j.bioorg.2018.01.020. Epub 2018 Jan 16.
10
Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.肉桂酸及其类似物的酰胺和酯衍生物的合成:对其自由基清除、单胺氧化酶和胆碱酯酶抑制活性的评估。
Chem Pharm Bull (Tokyo). 2017;65(11):1020-1027. doi: 10.1248/cpb.c17-00416.